Pancreatic Cancer Research

ResearcherShanghai Jiao Tong UniversityActive in the last 2 years

Pengyi Liu

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0009-0004-5084-7741; OpenAlex author ID A5102784679. Sources: OpenAlex.

Their work

Papers
9 (first author 2, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
42
Papers, trials and grants by year

2022: 1 paper · 2023: 1 paper · 2024: 3 papers · 2025: 3 papers · 2026: 1 paper

Papers 9

  1. Resident tissue macrophages transfer selenium transporter protein to protect pancreatic cancer from ferroptosis. Co-author DOI 10.1016/j.cell.2026.09.001↗
  2. Tumor-associated Schwann cell remodeling under metabolic stress via lactate sensing orchestrates pancreatic ductal adenocarcinoma development. Co-author DOI 10.1016/j.cmet.2025.07.008↗
  3. CTCF enhances pancreatic cancer progression via FLG-AS1-dependent epigenetic regulation and macrophage polarization. First author DOI 10.1038/s41418-024-01423-1↗
  4. Identification of a Novel Small Molecule STING Agonist Reshaping the Immunomicroenvironment of Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.7150/ijbs.107837↗
  5. BHLHE40 Inhibits Ferroptosis in Pancreatic Cancer Cells via Upregulating SREBF1. Co-author DOI 10.1002/advs.202306298↗
  6. ATF3-induced activation of NF-κB pathway results in acquired PARP inhibitor resistance in pancreatic adenocarcinoma. Co-author DOI 10.1007/s13402-023-00907-5↗
  7. Comprehensive analysis of KLF family reveals KLF6 as a promising prognostic and immune biomarker in pancreatic ductal adenocarcinoma. First author DOI 10.1186/s12935-024-03369-3↗
  8. A microprotein N1DARP encoded by LINC00261 promotes Notch1 intracellular domain (N1ICD) degradation via disrupting USP10-N1ICD interaction to inhibit chemoresi… Co-author DOI 10.1038/s41421-023-00592-6↗
  9. LncRNA-PACERR induces pro-tumour macrophages via interacting with miR-671-3p and m6A-reader IGF2BP2 in pancreatic ductal adenocarcinoma. Co-author DOI 10.1186/s13045-022-01272-w↗

Closest collaborators

The 25 strongest of 42 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Baiyong Shen · 7 shared papers, 2022–2025 · strength 1.21
  2. Yizhi Cao · 6 shared papers, 2022–2025 · strength 1.03
  3. Jiayu Lin · 5 shared papers, 2024–2025 · strength 0.99
  4. Yang Liu · 5 shared papers, 2024–2025 · strength 0.96
  5. Shuyu Zhai · 5 shared papers, 2023–2025 · strength 0.89
  6. Lingxi Jiang · 3 shared papers, 2024–2025 · strength 0.57
  7. Yihao Liu · 3 shared papers, 2022–2025 · strength 0.55
  8. Yihao Liu · 3 shared papers, 2024–2025 · strength 0.52
  9. Siyi Zou · 3 shared papers, 2022–2025 · strength 0.51
  10. Xiaomei Tang · 3 shared papers, 2023–2024 · strength 0.49
  11. Chenlei Wen · 3 shared papers, 2022–2025 · strength 0.47
  12. Chenghong Peng · 2 shared papers, 2024–2025 · strength 0.37
  13. Weishen Wang · 2 shared papers, 2024 · strength 0.34
  14. Youwei Zhu · 2 shared papers, 2024 · strength 0.34
  15. Jiewei Lin · 2 shared papers, 2023–2025 · strength 0.33
  16. Xiaxing Deng · 2 shared papers, 2023–2024 · strength 0.30
  17. Ronghao Zhang · 2 shared papers, 2023–2024 · strength 0.30
  18. Dongjie Chen · 1 shared paper, 2025 · strength 0.22
  19. Baiyong Shen · 1 shared paper, 2025 · strength 0.22
  20. Li Jiang · 1 shared paper, 2026 · strength 0.20
  21. Wei Guo · 1 shared paper, 2026 · strength 0.20
  22. Shulin Zhao · 1 shared paper, 2026 · strength 0.20
  23. Florent Ginhoux · 1 shared paper, 2026 · strength 0.20
  24. Camille Blériot · 1 shared paper, 2026 · strength 0.20
  25. Yishu Huang · 1 shared paper, 2024 · strength 0.20

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.